How has been the historical performance of Nath Bio-Genes?

Answer:The historical performance of Nath Bio-Genes shows a consistent growth in net sales and profitability over the past four years.

Breakdown:
Nath Bio-Genes has demonstrated a steady increase in net sales, rising from 278.36 Cr in Mar'22 to 364.91 Cr in Mar'25. The total operating income followed the same trend, reaching 364.91 Cr in Mar'25, up from 278.36 Cr in Mar'22. Despite the increase in sales, the total expenditure also grew, from 241.18 Cr in Mar'22 to 315.11 Cr in Mar'25, primarily driven by higher manufacturing expenses and selling and distribution costs. Operating profit, excluding other income, remained relatively stable, with a slight decrease from 49.86 Cr in Mar'24 to 49.80 Cr in Mar'25, while the overall operating profit increased to 54.35 Cr in Mar'25. Profit before tax improved significantly from a loss of 63.43 Cr in Mar'22 to a profit of 40.04 Cr in Mar'25. The profit after tax also showed a positive trend, increasing from a loss of 67.39 Cr in Mar'22 to a profit of 38.06 Cr in Mar'25. The earnings per share (EPS) improved from -35.46 in Mar'22 to 20.32 in Mar'25, reflecting the company's recovery and growth. Cash flow from operating activities decreased from 74.00 Cr in Mar'24 to 17.00 Cr in Mar'25, but the net cash inflow remained positive at 11.00 Cr in Mar'25, indicating a healthy cash position with closing cash and cash equivalents rising to 88.00 Cr. Overall, Nath Bio-Genes has shown a positive trajectory in its financial performance over the past four years.